Eloxx Pharmaceuticals (ELOX) news

Recent news

Eloxx Pharmaceuticals Q2 operating expenses USD 4.45 million

AInvest Wire · Aug 12, 2026

Eloxx Pharmaceuticals Q2 net income USD -4.502 million

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) reported a net loss of $4.5 million , or $(0.39) per share, for the second quarter ended June 30, 2026. The company also recorded a net loss of $8.3 million for the six months ended on the same date. Research and development expenses for the quarter…

AInvest Wire · Aug 12, 2026

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by